Product Information
GLIMEPIRIDE 2 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.0358 per EA under NDC 16729000216. Its NADAC has been published 506 times since Sep 14, 2016.
FDA first approved this application on Aug 23, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Glimepiride market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729000216
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
GLIMEPIRIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078181FDA Approved
8/23/2007
TE Code
AB
On Market Since
8/23/2007
Pharmacological Classes
Price Statistics
The NADAC for GLIMEPIRIDE 2 MG TABLET has been published 506 times since Sep 14, 2016, and over the history we have for it it has declined 70.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0358 per EA |
|---|---|
| All-time high | $0.1253 (Oct 12, 2016) |
| All-time low | $0.0284 (Apr 17, 2024) |
| 52-week high | $0.0371 |
| 52-week low | $0.0295 |
| Median price | $0.0565 |
| Average price | $0.0554 |
| Largest weekly change | -26.3% (Apr 17, 2024) |
| Weeks tracked | 506 |
| Tracking since | Sep 14, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
+21.5%
1Y
-3.6%
3Y
-0.2%
5Y
-29.2%
All
-70.7%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GLIMEPIRIDE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLIMEPIRIDE 2 MG TABLET, manufactured by Accord Healthcare Inc., is $0.0358 per EA (NDC 16729000216), effective May 20, 2026.
How has the price of GLIMEPIRIDE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLIMEPIRIDE 2 MG TABLET has declined 70.7%. It has been tracked across 506 weekly CMS publications since Sep 14, 2016.
What are the highest and lowest recorded NADAC prices for GLIMEPIRIDE 2 MG TABLET?
Since Sep 14, 2016, the NADAC for GLIMEPIRIDE 2 MG TABLET has ranged from a low of $0.0284 (Apr 17, 2024) to a high of $0.1253 (Oct 12, 2016), with a median of $0.0565 per EA.
Are there cheaper alternatives to GLIMEPIRIDE 2 MG TABLET?
10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GLIMEPIRIDE 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GLIMEPIRIDE 2 MG TABLET?
GLIMEPIRIDE 2 MG TABLET (NDC 16729000216) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.